MacroGenics Net Profit Margin 2012-2025 | MGNX

MacroGenics net profit margin from 2012 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
MacroGenics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-06-30 $0.17B $-0.04B -21.82%
2025-03-31 $0.15B $-0.06B -36.36%
2024-12-31 $0.15B $-0.07B -44.67%
2024-09-30 $0.14B $-0.10B -69.01%
2024-06-30 $0.04B $-0.14B -331.71%
2024-03-31 $0.04B $-0.02B -53.49%
2023-12-31 $0.06B $-0.01B -15.52%
2023-09-30 $0.12B $0.05B 41.67%
2023-06-30 $0.15B $0.01B 4.61%
2023-03-31 $0.17B $-0.09B -55.15%
2022-12-31 $0.15B $-0.12B -78.29%
2022-09-30 $0.09B $-0.19B -204.30%
2022-06-30 $0.07B $-0.22B -325.37%
2022-03-31 $0.07B $-0.22B -301.39%
2021-12-31 $0.08B $-0.20B -258.97%
2021-09-30 $0.12B $-0.15B -124.79%
2021-06-30 $0.12B $-0.13B -108.40%
2021-03-31 $0.11B $-0.14B -125.93%
2020-12-31 $0.11B $-0.13B -123.81%
2020-09-30 $0.08B $-0.16B -205.19%
2020-06-30 $0.08B $-0.17B -214.10%
2020-03-31 $0.07B $-0.15B -220.29%
2019-12-31 $0.07B $-0.15B -233.85%
2019-09-30 $0.06B $-0.17B -298.21%
2019-06-30 $0.06B $-0.16B -268.97%
2019-03-31 $0.07B $-0.17B -253.03%
2018-12-31 $0.06B $-0.17B -281.97%
2018-09-30 $0.20B $-0.02B -10.66%
2018-06-30 $0.18B $-0.03B -19.10%
2018-03-31 $0.16B $-0.03B -19.88%
2017-12-31 $0.16B $-0.02B -12.66%
2017-09-30 $0.01B $-0.16B -1463.64%
2017-06-30 $0.01B $-0.15B -1233.33%
2017-03-31 $0.09B $-0.07B -73.63%
2016-12-31 $0.09B $-0.06B -64.13%
2016-09-30 $0.10B $-0.05B -54.74%
2016-06-30 $0.11B $-0.03B -30.84%
2016-03-31 $0.03B $-0.09B -284.85%
2015-12-31 $0.10B $-0.02B -18.81%
2015-09-30 $0.10B $-0.01B -10.20%
2015-06-30 $0.10B $0.00B 0.99%
2015-03-31 $0.10B $0.01B 9.71%
2014-12-31 $0.05B $-0.04B -80.85%
2014-09-30 $0.06B $-0.02B -28.07%
2014-06-30 $0.06B $-0.01B -20.34%
2014-03-31 $0.06B 0 0.00%
2013-12-31 $0.06B 0 0.00%
2013-06-30 $0.04B $0.00B -7.69%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.114B $0.150B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.027B 26.85
Boston Scientific (BSX) United States $157.644B 37.59
Stryker (SYK) United States $150.755B 30.69
EssilorLuxottica (ESLOY) France $144.001B 0.00
Medtronic (MDT) Ireland $118.256B 16.67
Lonza Group Ag (LZAGY) Switzerland $50.628B 0.00
Haleon (HLN) United Kingdom $43.188B 24.69
ResMed (RMD) United States $41.753B 29.86
GE HealthCare Technologies (GEHC) United States $33.827B 15.90
Agilent Technologies (A) United States $33.605B 21.91
Koninklijke Philips (PHG) Netherlands $26.779B 17.71
Terumo (TRUMY) Japan $26.532B 31.44
Insulet (PODD) United States $23.358B 78.26
Zimmer Biomet Holdings (ZBH) United States $21.303B 13.56
Smith & Nephew SNATS (SNN) United Kingdom $16.337B 0.00
Baxter (BAX) United States $12.584B 9.72
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $8.027B 29.48
Lantheus Holdings (LNTH) United States $3.785B 10.23
Envista Holdings (NVST) United States $3.513B 24.58
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.268B 14.50
Perrigo (PRGO) Ireland $3.265B 8.15
ICU Medical (ICUI) United States $3.109B 21.17
Haemonetics (HAE) United States $2.661B 11.88
LeMaitre Vascular (LMAT) United States $2.157B 46.25
Acuren (TIC) United States $2.156B 0.00
Curaleaf Holdings (CURLF) Canada $2.117B 0.00
QuidelOrtho (QDEL) United States $1.896B 11.93
Green Thumb Industries (GTBIF) United States $1.888B 81.09
AtriCure (ATRC) United States $1.882B 0.00
Tilray Brands (TLRY) Canada $1.596B 0.00
Phibro Animal Health (PAHC) United States $1.323B 16.91
AdaptHealth (AHCO) United States $1.246B 17.71
BioLife Solutions (BLFS) United States $1.229B 2565.00
Neogen (NEOG) United States $1.223B 19.41
Kestra Medical Technologies (KMTS) United States $0.952B 0.00
InMode (INMD) Israel $0.941B 8.70
Valneva SE (VALN) France $0.762B 0.00
Cresco Labs (CRLBF) United States $0.683B 0.00
SNDL (SNDL) Canada $0.649B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.618B 0.00
Verano Holdings (VRNOF) United States $0.615B 0.00
ZimVie (ZIMV) United States $0.535B 20.62
Surmodics (SRDX) United States $0.496B 0.00
Evolus (EOLS) United States $0.495B 0.00
VAREX IMAGING (VREX) United States $0.468B 16.11
CeriBell (CBLL) United States $0.420B 0.00
Owens & Minor (OMI) United States $0.387B 3.43
Sanuwave Health (SNWV) United States $0.360B 0.00
Canopy Growth (CGC) Canada $0.353B 0.00
TerrAscend (TSNDF) Canada $0.352B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Brainsway (BWAY) Israel $0.301B 61.15
Sanara MedTech (SMTI) United States $0.300B 0.00
Aurora Cannabis (ACB) Canada $0.299B 0.00
Omeros (OMER) United States $0.298B 0.00
Capricor Therapeutics (CAPR) United States $0.296B 0.00
High Tide (HITI) Canada $0.283B 0.00
Viemed Healthcare (VMD) United States $0.273B 20.74
Cerus (CERS) United States $0.255B 0.00
OraSure Technologies (OSUR) United States $0.255B 0.00
TriSalus Life Sciences (TLSI) United States $0.254B 0.00
Vireo Growth (VREOF) United States $0.241B 0.00
Organigram Global (OGI) Canada $0.221B 0.00
Quanterix (QTRX) United States $0.218B 0.00
Exagen (XGN) United States $0.218B 0.00
Utah Medical Products (UTMD) United States $0.195B 16.24
FitLife Brands (FTLF) United States $0.173B 21.31
Biote (BTMD) United States $0.164B 5.43
Jushi Holdings (JUSHF) United States $0.151B 0.00
Jin Medical (ZJYL) China $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 12.32
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.068B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 32.90
Veru (VERU) United States $0.051B 0.00
Zynex (ZYXI) United States $0.050B 0.00
Nephros (NEPH) United States $0.043B 33.67
Rockwell Medical (RMTI) United States $0.043B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 14.62
Trinity Biotech (TRIB) Ireland $0.027B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.018B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Sharps Technology (STSS) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00